1. H Lundbeck
2. Pfizer Inc
3. AbbVie
4. AstraZeneca
5. Bristol Myers Squibb
6. Eli Lilly
7. GlaxoSmithKline
8. Johnson & Johnson
9. Takeda Pharmaceuticals
10. Novartis AG
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 165 | Renub Research | ASDR-638610 |
1. H Lundbeck
2. Pfizer Inc
3. AbbVie
4. AstraZeneca
5. Bristol Myers Squibb
6. Eli Lilly
7. GlaxoSmithKline
8. Johnson & Johnson
9. Takeda Pharmaceuticals
10. Novartis AG